Cbc Chemotypes

CBC (cannabichromene) chemotypes represent cannabis plants that produce elevated levels of CBC as a primary or secondary cannabinoid, often alongside CBD, THC, or other minor cannabinoids. These chemotypes are less common than THC or CBD-dominant profiles, making them of particular interest to breeders developing diverse cannabinoid portfolios. CBC is produced through the same biosynthetic pathway as CBD and THC, diverging at the cyclase enzyme stage, which means genetic selection for CBC expression requires understanding of underlying cannabinoid synthase genetics. Lineage records indicate CBC-forward cultivars emerge sporadically from global breeding programs, particularly those working with landrace genetics or advanced crossing projects. The stability and expression of CBC in offspring varies considerably depending on parental genotypes and environmental factors during development.

Breeders pursuing CBC chemotypes typically employ test-crossing and cannabinoid profiling (via HPLC or similar methods) to identify and stabilize CBC-expressing lines. Understanding the genetic basis of cannabinoid pathway regulation is essential for predictably producing CBC-dominant or CBC-rich offspring across generations.